Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction
Caceres-Dittmar G, Tapia FJ, Sanchez MA et al. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol 1993; 91: 500-5.
Intermediate or chronic cutaneous leishmaniasis: Leukocyte immunophenotypes and cytokine characterisation of the lesion
Diaz NL, Zerpa O, Ponce LV et al. Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterisation of the lesion. Exp Dermatol 2002; 11: 34-41.
Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages
Huang FP, Niedbala W, Wei XQ et al. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. European J Immunol 1998; 28: 4062-70.
Expression of inducible nitric oxide synthase in skin lesions of patients with American cutaneous leishmaniasis
Qadoumi M, Becker I, Donhauser N et al. Expression of inducible nitric oxide synthase in skin lesions of patients with American cutaneous leishmaniasis. Infection Immunity 2002; 70: 4638-42.
Tumor necrosis factor-alpha syn-ergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide
Liew FY, Li Y, Millott S. Tumor necrosis factor-alpha syn-ergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 1990; 145: 4306-10.
In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease
Himmelrich H, Launois P, Maillard I et al. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J Immunol 2000; 164: 4819-25.
